Ivelina Spassova

MHC class-I downregulation in PD-1/PD-L1 inhibitor refractory Merkel cell carcinoma and its potential reversal by histone deacetylase inhibition: a case series

Selma Ugurel, Ivelina Spassova, Jonas Wohlfarth et al. · Cancer Immunology Immunotherapy · 2019 · 83 citations · Full text

Medicine, Immunology, Oncology +17

Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma

Ivelina Spassova, Selma Ugurel, Patrick Terheyden et al. · Clinical Cancer Research · 2020 · 73 citations

Life Sciences, Immunology, Oncology +17

Merkel cell carcinoma-derived exosome-shuttle miR-375 induces fibroblast polarization by inhibition of RBPJ and p53

Kaiji Fan, Ivelina Spassova, Jan Gravemeyer et al. · Oncogene · 2020 · 47 citations · Full text

Medicine, Cell Biology, Oncology +17

Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma

Ivelina Spassova, Selma Ugurel, Linda Kubat et al. · Journal for ImmunoTherapy of Cancer · 2022 · 45 citations · Full text

Life Sciences, Immunology, Oncology +17

The HDAC Inhibitor Domatinostat Promotes Cell-Cycle Arrest, Induces Apoptosis, and Increases Immunogenicity of Merkel Cell Carcinoma Cells

Lina Song, Anne Catherine Bretz, Jan Gravemeyer et al. · Journal of Investigative Dermatology · 2020 · 44 citations · Full text

Medicine, Oncology, Pharmacology +17